Get started
Work

Figures S4A and S4B from RELAY Subgroup Analyses by EGFR Ex19del and Ex21L858R Mutations for Ramucirumab Plus Erlotinib in Metastatic Non–Small Cell Lung Cancer

Year: 2023
Type: other
Abstract: Summary of (A) progression type, and (B) single site versus multiple-site progression, by baseline activating EGFR mutation subgroup.
DOI: 10.1158/1078-0432.23459208
Authors: Kazuhiko Nakagawa, Ernest Nadal, Edward B. Garon, Makoto Nishio, Takashi Seto, Nobuyuki Yamamoto, Keunchil Park, Jin-Yuan Shih, Luis Paz-Ares, Bente Frimodt-Moller, Annamaria H. Zimmermann, Sameera Wijayawardana, Carla Visseren-Grul, Martin Reck
Language: English
Field: Medicine
Open Access status: gold
OpenAlex ID: W4380028551
Cites:
Cited by:
Related to: 10